CEMI Chembio Diagnostics Inc

Chembio Diagnostics Inc develops, manufacture markets & licenses rapid point of care diagnostic tests that detect infectious diseases. Its products are rapid tests for the detection of HIV 1/2 antibodies, & for the detection of HIV & Syphilis antibodies.

As of 01/26/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  06/07/2012
Outstanding shares:  30,045,141
Average volume:  1,006,551
Market cap:   $27,223,902
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   -1.01
PB ratio:   0.57
PS ratio:   0.99
Return on equity:   -56.49%
Net income %:   -98.71%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy